Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
ProShares UltraPro Short S&P500 ETF
SPXU
5
T-Rex 2X Inverse MSTR Daily Target ETF
MSTZ
US Stock MarketDetailed Quotes
VYNE VYNE Therapeutics
- 1.430
- +0.060+4.38%
Close May 5 16:00 ET
21.75MMarket Cap-1.54P/E (TTM)
1.440High1.320Low138.73KVolume1.380Open1.370Pre Close190.80KTurnover1.31%Turnover RatioLossP/E (Static)15.21MShares4.30052wk High0.42P/B15.14MFloat Cap1.27052wk Low--Dividend TTM10.58MShs Float2869.920Historical High--Div YieldTTM8.74%Amplitude1.270Historical Low1.375Avg Price1Lot Size
VYNE Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 18.16%501K | 10.53%84K | 6.14%121K | 46.67%198K | -1.01%98K | -11.11%424K | 1,166.67%76K | -31.74%114K | 7.14%135K | -44.38%99K |
| Operating revenue | 18.16%501K | 10.53%84K | 6.14%121K | 46.67%198K | -1.01%98K | -11.11%424K | 1,166.67%76K | -31.74%114K | 7.14%135K | -44.38%99K |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 48.70%44.14M | 86.07%12.85M | 108.13%13.21M | 1.35%10.59M | 25.18%7.48M | -14.64%29.68M | -13.54%6.91M | -33.18%6.35M | 24.25%10.45M | -32.64%5.97M |
| Selling and administrative expenses | -1.37%13.19M | -18.40%3.17M | -2.18%2.96M | 2.11%3.29M | 16.36%3.77M | -18.38%13.38M | 4.69%3.89M | -23.37%3.03M | -25.20%3.22M | -26.65%3.24M |
| -General and administrative expense | -1.37%13.19M | -18.40%3.17M | -2.18%2.96M | 2.11%3.29M | 16.36%3.77M | -18.38%13.38M | --3.89M | --3.03M | --3.22M | --3.24M |
| Research and development costs | 89.77%30.95M | 220.34%9.68M | 208.86%10.25M | 1.01%7.31M | 35.63%3.71M | -11.30%16.31M | -29.35%3.02M | -40.17%3.32M | 76.07%7.23M | -38.59%2.73M |
| Operating profit | -49.15%-43.64M | -86.91%-12.77M | -109.99%-13.09M | -0.76%-10.4M | -25.62%-7.38M | 14.69%-29.26M | 14.43%-6.83M | 33.20%-6.23M | -24.51%-10.32M | 32.40%-5.88M |
| Net non-operating interest income expense | ||||||||||
| Other net income (expense) | 176.62%3.83M | 11.76%760K | 473.01%934K | 257.50%1M | 333.08%1.14M | 281.82%1.39M | 188.14%680K | 108.97%163K | 438.46%280K | 8,866.67%263K |
| Other non- operating income (expenses) | 176.62%3.83M | 11.76%760K | 473.01%934K | 257.50%1M | 333.08%1.14M | 281.82%1.39M | 188.14%680K | 108.97%163K | 438.46%280K | 8,866.67%263K |
| Income before tax | -42.81%-39.8M | -95.22%-12.01M | -100.25%-12.16M | 6.41%-9.4M | -11.21%-6.24M | 17.86%-27.87M | 20.60%-6.15M | 34.40%-6.07M | -21.89%-10.04M | 35.45%-5.61M |
| Income tax | 4K | 4K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | -40.00%-39.83M | -94.28%-12.02M | -84.64%-12.16M | 6.48%-9.41M | -11.15%-6.25M | -22.59%-28.45M | 37.78%-6.19M | 30.39%-6.58M | -18.66%-10.06M | -220.39%-5.62M |
| Net income continuous Operations | -42.82%-39.81M | -95.29%-12.01M | -100.25%-12.16M | 6.41%-9.4M | -11.21%-6.24M | 17.89%-27.87M | 20.73%-6.15M | 34.40%-6.07M | -21.89%-10.04M | 35.45%-5.61M |
| Net income discontinuous operations | 95.34%-27K | 77.78%-8K | --0 | 45.00%-11K | 20.00%-8K | -105.40%-580K | 98.35%-36K | -151.47%-513K | 91.70%-20K | -100.07%-10K |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -40.00%-39.83M | -94.28%-12.02M | -84.64%-12.16M | 6.48%-9.41M | -11.15%-6.25M | -22.59%-28.45M | 37.78%-6.19M | 30.39%-6.58M | -18.66%-10.06M | -220.39%-5.62M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -40.00%-39.83M | -94.28%-12.02M | -84.64%-12.16M | 6.48%-9.41M | -11.15%-6.25M | -22.59%-28.45M | 37.78%-6.19M | 30.39%-6.58M | -18.66%-10.06M | -220.39%-5.62M |
| Basic earnings per share | 66.55%-0.93 | 36.20%-0.28 | 85.57%-0.29 | 92.88%-0.22 | 91.38%-0.15 | 61.81%-2.78 | 86.82%-0.4389 | 31.63%-2.01 | -17.49%-3.09 | -215.23%-1.74 |
| Diluted earnings per share | 66.55%-0.93 | 36.20%-0.28 | 85.57%-0.29 | 92.88%-0.22 | 91.38%-0.15 | 61.81%-2.78 | 86.82%-0.4389 | 31.63%-2.01 | -17.49%-3.09 | -215.23%-1.74 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now